Send me a link:

*Text messaging rates may apply.

 Dow Up 0.37% Nasdaq Up 0.69%

Conatus Pharmaceuticals Inc. (CNAT)

-NasdaqGM
7.75 Down 0.15(1.90%) 3:55PM EDT - Nasdaq Real Time Price
Prev Close:7.90
Open:7.98
Bid:7.72 x 100
Ask:7.76 x 3100
1y Target Est:16.00
Beta:-0.520
Next Earnings Date:N/A
Day's Range:7.66 - 8.24
52wk Range:5.06 - 15.67
Volume:374,865
Avg Vol (3m):682,751
Market Cap:119.54M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CNATDown 1.90%119.54M
GALTDown 0.15%295.10M
ICPTUp 1.96%4.69B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.66
Quarterly EPS Est (Jun-14) :-0.40
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-4.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback